Volume : 10, Issue : 11, November – 2023
Title:
APPLICATION OF 3D PRINTING TECHNOLOGY IN PHARMACEUTICALS
Authors :
Kalyani Mankar*, Shailesh Jawarkar, Priyash Wankhade, Shreyash Padmawar, Isha Paranjape
Abstract :
Three-dimensional printing is a revolutionary technique that uses computer aided design software and programming to create three dimensional objects by placing material on a substrate. 3D printing is an additive layer manufacturing techniques, where consecutive layers of material are deposited or solidified to form a 3D structure. Medicinal substances is configured in three dimensional with computer assisted design module and transformed to a machine legible form which suggests the exterior emerge of the 3D dose form, then it sliced this surface into number of different printable coats and convey these layers to the machine. The different 3D printing techniques has been developing and developed to fabricate novel solid dosage forms, which are among the most well-known and discrete products today. The 3D PRINTING technology has caught the attention of medical devices industry and pharmaceutical industry due to its applications on various platform in health care industry. Even though this technology exists for a long time it is of public interest highly now due to the approval of 3-D printed tablet and other medical devices and also with the advent of USFDA’s guidance on technical considerations specific to devices using additive manufacturing which encompasses 3-dimensional (3D) printing has triggered many thoughts about this technology which needs to be considered for successful delivery of intended product. This paper presents regulatory agencies expectations, limitations, problems in establishing such setups for production of drug products, advantages, disadvantages, applications, methods and associated risks involved in manufacturing. It also provides the comprehensive review of the current status of research and development on this platform.
Cite This Article:
Please cite this article in press Kalyani Mankar et al, Aapplication of 3D printing technology in Pharmaceuticals, Indo Am. J. P. Sci, 2023; 10 (11).
Number of Downloads : 10
References:
1. Norman J, Madurawe R, Moore C, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Advanced Drug Delivery Reviews.2017; 108:39-50.
2. UrsanI,Chiu L, Pierce A; Three-dimensional drug printing: a structured review. Journal of the American Pharmacists Association; 2013; P: 53.
3. Marzuka SK, Kulsum JU; 3D Printing: a new avenue in pharmaceuticals. World Journal of Pharmaceutical Research;2016; 5:1686-701.
4. Food and Drug Administration,2017. Guidance for Industry: Technical Considerations for Additive Manufactured Medical Devices. Center for Devices and Radiological Health Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services.
5. Norman J, Madurawe R, Moore C, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Advanced Drug Delivery Reviews.2017; 108:39-50.
6. Andrea AK,MartaGP,DoloresRS.Personalised 3DPrinted Medicines: Which Techniques and Polymers Are More Successful?.Bioengineering. 2017; 4(79), 1-16.
7. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ (2015) 3D printing of fiveinone dose combination polypill with defined immediate and sustained release profiles. Journal of controlled release 217:308-314.
8. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. International Journal of Pharmaceutics. 2015; 494(2): 643-50
9. Scoutaris N, Alexander M, Gellert P, Roberts C. Inkjet printing as a novel medicine formulation technique. Journal of Controlled Release. Volume 156, Issue 2, 10 December 2011, P-179-185.
10. Lee BK, Yun YH, Choi JS, Choi YC, Kim JD, Cho YW. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system.International Journal of Pharmaceutics. 2012; 427 (2): 305–10.
11. Yao xuexuebao: 3D printing via fused deposition modeling in pharmaceutics; Acta pharmaceutical Sinica, November 2016,51(11):P-1659-1665.
12. Yao xuexuebao ;3D printing via fused deposition modeling in pharmaceutics; ActapharmaceuticaSinica, November 2016,(11): P-1659-1665 .
13. ApreciaPharmacuticals. FDA approves the first 3D printed drug product aprecia introduces its first product using the ZipDose® formulation platform for the treatment of epilepsy; 2015.
14. Herbert Reitsamer ,JohannesKhinast.; 3D printing of oraldrugs: a new reality or hype.;Expert Opinion on Drug Delivery;05 Sep 2017 , Volume 15, 2018 – Issue I.
15. Rattanakit P, Moulton SE, Santiago KS, Liawruangrath S, Wallace GG. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms.; International journal of pharmaceutics ;2012;422:254-63.
16. SampadaUpadhye;Hot melt extrusion – optimelt™ Hot Melt Extrusion Technology to Improve Bioavailability of Poorly Soluble Drugs; drug development and delivery;2015
17. SonalKushwaha.; Application of Hot Melt Extrusion in Pharmaceutical 3D Printing, Journal of Bioequivalence & Bioavailability; 2018, Vol 10(3): 54-57.
18. Jie Wang , Alvaro Goyanes , Simon Gaisford , Abdul W. Ba sit.;Stereolithographic (SLA) 3D printing of oral modified-r elease dosage forms.; International journal of pharmaceutics; 30 April 2016, Volume 503, P- 207-212.
19. Pamela Robles; Production of medicines using stereolithography (SLA) 3D printing, fab Rx; September 28, 2017.
20. Fina F, Madla CM, Goyanes A, Zhang J, Gaisford S, Basit AW.; Fabricating 3D printed orally disintegrating printlets using selective laser sintering.;InternationalJournalofPharmaceutics.;2018,541(1–2):101–107.
21. Goyanes A, Fina F, Martorana A, Sedough D, Gaisford S, Basit AW. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.Int J Pharm. 2017;527(1-2):21-30.
22. Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emer- Ponnigence of 3D printed dosage forms: Opportunities and challenges. Pharm Res. 2016;33(8):1817-
23. 32.
24. Lim SH, Chia SM, Kang L, Yap KY. Three-dimensional printing of carbamazepine sustained-release scaffold. J Pharm Sci. 2016;105(7):2155-63.
25. Bansal M, Sharma V, Singh G, Harikumar SL. 3D Printing for the Future of Pharmaceuticals Dosages Forms. Int J Pharm Pharm Sci. 2018;10(3):1-7.
26. Bala R, Madaan R, Kaur A, Mahajan K, Singh NM, Sohal NA, et al. 3D printing: Basic role in pharmacy. Eur J Biomed Pharm Sci. 2017;4:242-7.
27. Fiona B. FDA approves the first 3D printed drug. Aprecia Pharmaceuticals.In Pharma Technologist. 2015.
28. Hsiao WK, Lorber B, Reitsamer H, Khinast J. 3D printing of oral drugs: A new reality or hype?.Expert Opin Drug Deliv. 2017;15(1):1-4.
29. Feng X, Zhang F. Twin-screw extrusion of sustained-release oral dosage forms and medical implants. Drug DelivTransl Re. 2018;8(6):1694-713.
30. Repka MA, Bandari S, Kallakunta VR, Vo AQ, McFall H, Pimparade MB, et al. Melt extrusion with poorly soluble drugs: An integrated review. Int J Pharm. 2018;535(12):68-85.
31. Latief AD, Suhardi P, Badri C. Three-dimensional model printing in oral and maxillofacial reconstructive surgery: Comparison of three-dimensional models and multislice computed tomography scans. Int J Appl Pharm. 2017;9(Special Issue 2):74-8.
32. Martinez PR, Basit AW, Gaisford S. The history, developments and opportunities of stereolithography.In 3D Printing of Pharmaceuticals.Springer, Cham. 2018;55-79.
33. Fina F, Madla CM, Goyanes A, Zhang J, Gaisford S, Basit AW. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Int J Pharm. 2018;541(12):101-
34. Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017;108:39-
35. Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, Cima MJ. Oral dosage forms fabricated by Three Dimensional Printing™.J Control Release. 2000;66(1):1-9.
36. Katakam P, Dey B, Assaleh FH, Hwisa NT, Adiki SK, Chandu BR, et al. Top-down and bottom-up approaches in 3D printing technologies for drug delivery challenges. C Crit Rev Ther Drug. 2015;32(1):61-87.
37. Goyanes A, Wang J, Buanz A, Martínez-Pacheco R, Telford R, Gaisford S, Basit AW. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics. 2015; 12(11):4077-84
38. Chai X, Chai H, Wang X, Yang J, Li J, Zhao Y, Cai W, Tao T, Xiang X. Fused Deposition Modeling (FDM)3D Printed Tablets for Intragastric Floating Delivery of Domperidone. Scientific Reports.2017; 7: 2829.
39. Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. European Journal of Pharmaceutical Sciences. 2015; 68:11–7
40. Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW. 3D printing of modifiedrelease aminosalicylate (4-ASA and 5-ASA) tablets.European Journal of Pharmaceutics and Biopharmaceutics. 2014; 89: 157–62.